Pharma Equity Group A/S
PEG.CO · CPH
6/30/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | DKK 124,800 | DKK 194,360 | DKK 238,347 | DKK 306,885 |
| - Cash | DKK 702 | DKK 1,544 | DKK 3,770 | DKK 863 |
| + Debt | DKK 18,452 | DKK 11,045 | DKK 52,686 | DKK 43,879 |
| Enterprise Value | DKK 142,550 | DKK 203,861 | DKK 287,263 | DKK 349,901 |
| Revenue | – | DKK 0 | DKK 0 | DKK 0 |
| % Growth | – | – | – | – |
| Gross Profit | – | DKK 0 | -DKK 124 | -DKK 124 |
| % Margin | – | – | – | – |
| EBITDA | – | -DKK 4,221 | -DKK 5,117 | -DKK 4,864 |
| % Margin | – | – | – | – |
| Net Income | – | -DKK 4,645 | -DKK 6,746 | -DKK 5,861 |
| % Margin | – | – | – | – |
| EPS Diluted | – | -0.006 | -0.006 | -0.006 |
| % Growth | – | -1.7% | -3.5% | – |
| Operating Cash Flow | – | -DKK 6,659 | -DKK 4,503 | -DKK 3,871 |
| Capital Expenditures | – | DKK 0 | DKK 0 | DKK 0 |
| Free Cash Flow | – | -DKK 6,659 | -DKK 4,503 | -DKK 3,871 |